BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12501244)

  • 1. Localization of the discontinuous immunodominant region recognized by human anti-thyroperoxidase autoantibodies in autoimmune thyroid diseases.
    Bresson D; Cerutti M; Devauchelle G; Pugnière M; Roquet F; Bes C; Bossard C; Chardès T; Péraldi-Roux S
    J Biol Chem; 2003 Mar; 278(11):9560-9. PubMed ID: 12501244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Directed mutagenesis in region 713-720 of human thyroperoxidase assigns 713KFPED717 residues as being involved in the B domain of the discontinuous immunodominant region recognized by human autoantibodies.
    Bresson D; Pugnière M; Roquet F; Rebuffat SA; N-Guyen B; Cerutti M; Guo J; McLachlan SM; Rapoport B; Estienne V; Ruf J; Chardès T; Péraldi-Roux S
    J Biol Chem; 2004 Sep; 279(37):39058-67. PubMed ID: 15150267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the conformational dominant epitopes on thyroid peroxidase recognized by human autoantibodies.
    Bresson D; Rebuffat SA; Nguyen B; Banga JP; Gardas A; Peraldi-Roux S
    Endocrinology; 2005 Jun; 146(6):2834-44. PubMed ID: 15761037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into autoreactive determinants in thyroid peroxidase composed of discontinuous and multiple key contact amino acid residues contributing to epitopes recognized by patients' autoantibodies.
    Dubska M; Banga JP; Plochocka D; Hoser G; Kemp EH; Sutton BJ; Gardas A; Gora M
    Endocrinology; 2006 Dec; 147(12):5995-6003. PubMed ID: 16959834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis.
    Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of conformational epitopes on thyroid peroxidase by antipeptide antibody binding and mutagenesis.
    Gora M; Gardas A; Wiktorowicz W; Hobby P; Watson PF; Weetman AP; Sutton BJ; Banga JP
    Clin Exp Immunol; 2004 Apr; 136(1):137-44. PubMed ID: 15030525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of autoantibody epitopes on human thyroid peroxidase.
    Grennan Jones F; Ziemnicka K; Sanders J; Wolstenholme A; Fiera R; Furmaniak J; Rees Smith B
    Autoimmunity; 1999; 30(3):157-69. PubMed ID: 10520899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rarity of autoantibodies to a major autoantigen, thyroid peroxidase, that interact with denatured antigen or with epitopes outside the immunodominant region.
    Guo J; Wang Y; Jaume JC; Rapoport B; McLachlan SM
    Clin Exp Immunol; 1999 Jul; 117(1):19-29. PubMed ID: 10403911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Search for the autoantibody immunodominant region on thyroid peroxidase: epitopic footprinting with a human monoclonal autoantibody locates a facet on the native antigen containing a highly conformational epitope.
    Guo J; Yan XM; McLachlan SM; Rapoport B
    J Immunol; 2001 Jan; 166(2):1327-33. PubMed ID: 11145717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of the thyroid peroxidase autoantibody immunodominant region to a junctional region containing portions of the domains homologous to complement control protein and myeloperoxidase.
    Guo J; McLachlan SM; Rapoport B
    J Biol Chem; 2002 Oct; 277(43):40189-95. PubMed ID: 12167622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that the complement control protein-epidermal growth factor-like domain of thyroid peroxidase lies on the fringe of the immunodominant region recognized by autoantibodies.
    Pichurin PN; Guo J; Estienne V; Carayon P; Ruf J; Rapoport B; McLachlan SM
    Thyroid; 2002 Dec; 12(12):1085-95. PubMed ID: 12593722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique autoantibody epitopes in an immunodominant region of thyroid peroxidase.
    Arscott PL; Koenig RJ; Kaplan MM; Glick GD; Baker JR
    J Biol Chem; 1996 Mar; 271(9):4966-73. PubMed ID: 8617771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of mouse monoclonal antibodies for identification of antigen regions of human thyroid peroxidase in adolescents with Graves' disease and non-toxic multinodular goiter by flow cytometry.
    Bossowski A; Stasiak-Barmuta A; Czarnocka B; Urban M; Dadan J
    Autoimmunity; 2005 Dec; 38(8):605-11. PubMed ID: 16390813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human anti-thyroid peroxidase autoantibody repertoire in Graves' and Hashimoto's autoimmune thyroid diseases.
    Chardès T; Chapal N; Bresson D; Bès C; Giudicelli V; Lefranc MP; Péraldi-Roux S
    Immunogenetics; 2002 Jun; 54(3):141-57. PubMed ID: 12073143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of autoantibodies against thyroid peroxidase in autoimmune thyroid disease: evidence against antibodies directly inhibiting peroxidase activity as regulatory factors in thyroid hormone metabolism.
    Saller B; Hörmann R; Mann K
    J Clin Endocrinol Metab; 1991 Jan; 72(1):188-95. PubMed ID: 1702446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies and monoclonal antibodies directed to an immunodominant antigenic region of thyroglobulin interact with thyroperoxidase through an interspecies idiotype.
    Ruf J; Ferrand M; Durand-Gorde JM; Carayon P
    Autoimmunity; 1994; 19(1):55-62. PubMed ID: 7749042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of key amino acid residues in the dominant conformational epitopes on thyroid peroxidase recognized by mouse monoclonal antibodies.
    Godlewska M; Czarnocka B; Gora M
    Autoimmunity; 2012 Sep; 45(6):476-84. PubMed ID: 22559245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter study on TGPO autoantibody prevalence in various thyroid and non-thyroid diseases; relationships with thyroglobulin and thyroperoxidase autoantibody parameters.
    Estienne V; Duthoit C; Costanzo VD; Lejeune PJ; Rotondi M; Kornfeld S; Finke R; Lazarus JH; Feldt-Rasmussen U; Franke WG; Smyth P; D'Herbomez M; Conte-Devolx B; Persani L; Carella C; Jourdain JR; Izembart M; Toubert ME; Pinchera A; Weetman A; Sapin R; Carayon P; Ruf J
    Eur J Endocrinol; 1999 Dec; 141(6):563-9. PubMed ID: 10601957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human thyroperoxidase folds in one complex B-cell immunodominant region.
    Blanchin S; Estienne V; Guo J; Rapoport B; McLachlan SM; Carayon P; Ruf J
    Biochem Biophys Res Commun; 2002 Aug; 295(5):1118-24. PubMed ID: 12135610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The key residues in the immunodominant region 353-363 of human thyroid peroxidase were identified.
    Rebuffat SA; Bresson D; Nguyen B; Péraldi-Roux S
    Int Immunol; 2006 Jul; 18(7):1091-9. PubMed ID: 16735377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.